# Stage 12 — Stage 3 Ontology Human-Review Recommendation

**Status:** REVIEWED — RECOMMEND APPROVE ALL 53  
**Date:** 31 August 2026  
**Packet:** `components/evidence-registry/review-packets/stage12-seed/stage3_ontology.json`  
**Packet SHA-256:** `cdd59fea33393dfd985c603d31db62f7b3a713ce82c5e8cbc9d92351502d5e90`  
**Scientific revision at packet generation:** `1679`

## Decision

Recommend **approve 53 / correct 0 / reject 0**.

This recommendation is an AI-assisted scientific review of the governed packet. It is not itself human approval. A human owner must explicitly execute the governed batch-approval operation after reading this review.

## Review criteria

Each mapping was checked against the Stage 3 scientific separations:

```text
APPLICATION FAMILY = where evidence may be useful
TARGET LOCUS       = level at which change is attempted/observed
TARGET             = specific process/capacity/state/policy/system property
MECHANISM          = proposed/tested process producing an effect
ROUTE              = how/where an intervention acts
```

The review specifically looked for:

- application-family mappings that would imply efficacy or product validation;
- `performance` mappings that would turn laboratory outcomes into real-world effectiveness claims;
- targets that merely repeat intervention-route labels;
- physiological targets inferred more narrowly than the seed supports;
- mechanism assertions that imply mediation or causality where only association/mechanistic relevance is established;
- AI/workflow mappings that conflate task allocation, strategy, route and outcome.

## Findings

### Application-family mappings

All proposed application-family mappings are acceptable as **relevance lenses**, not efficacy claims.

The mappings most likely to look broad on a first read remain acceptable because their relevance level and rationale constrain them:

- `rt-2026-004` and `rt-2026-010` map to `performance` only as **secondary** relevance. They do not claim real-world effectiveness; they identify analogy/relational reasoning and perceptual-generalisation performance as potentially relevant to the performance family.
- `rt-2026-012` uses `performance` as the primary application lens for mechanistic acute-stress evidence. This is acceptable because the record concerns the operating state in which prediction and episodic encoding compete; it does not claim a performance intervention effect. `wellbeing` remains secondary.
- Older-adult records use `longevity` only where ageing/maintenance is genuinely part of the evidential context. The mappings do not imply lifespan extension or clinical prevention.
- `rt-2026-018` is explicitly observational; its `performance` and secondary `learning` relevance therefore do not imply causal benefit from AI offloading.

### Target mappings

All proposed component targets are acceptable and remain distinct from route.

Notable checks:

- `target_physical_conditioning` is intentionally broad and sits at the `biological_or_physiological_substrate` locus. For Baduanjin this is safer than inventing an unmeasured narrower physiological mediator.
- `target_feedback_architecture`, `target_mastery_progression_policy`, and `target_human_ai_task_allocation` are legitimate `niche_or_activity_system` targets: they describe properties of the activity system being manipulated rather than re-labelling the `Redesign` or `Integrate` routes.
- `target_metacognitive_monitoring_strategy` is legitimate for the bounded-AI condition because compulsory reflection is an explicit strategy/policy element rather than an inferred cognitive mechanism.
- broad multi-domain targets are used only where the intervention explicitly spans several cognitive operations.

### Mechanism assertions

The four mechanism assertions are acceptable as currently typed:

- relational-structure consolidation;
- temporal-integration/generalisation;
- confidence-gated error learning;
- stress-induced prediction shift.

They are all coded as `hrp_candidate` with explicit supporting summaries. None is promoted to a mediator-supported or experimentally demonstrated causal pathway merely because the relationship is mechanistically informative.

## Governance conclusion

The Stage 3 packet is sufficiently conservative for human approval **without changing any scientific value**.

Recommended batch action:

```text
approve = 53
correct = 0
reject = 0
```

Human approval should:

1. verify the packet SHA and unchanged scientific row snapshots;
2. create Stage 11 human adjudication/authority records for all 53 bridged candidates;
3. preserve the proposed scientific values unchanged;
4. change the corresponding normalized mapping provenance to `human_review` and review state to `approved`;
5. leave the historical `2026-08-23` release and CSI Gateway untouched.
